Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance-Reference-Cited by-同舟云学术

Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+ T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance

Published:2024-08 Issue: Volume:137 Page:112461
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Fan Zhiwen^ORCID,Ye Mingzhu,Liu Dan,Zhou Wenchao,Zeng Tian,He Sili,Li Yukun

Funder

National Natural Science Foundation of China

Central South University

Natural Science Foundation of Hunan Province

Publisher

Elsevier BV

Reference46 articles.

1. Ovarian cancer statistics;Torre;CA Cancer J. Clin.,2018

2. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer;Song;Eur. J. Med. Chem.,2022

3. Cisplatin increases immune activity of monocytes and cytotoxic T-cells in a murine model of epithelial ovarian cancer;Hopkins;Transl. Oncol.,2021

4. Lactate upregulates the expression of DNA repair genes, causing intrinsic resistance of cancer cells to cisplatin;Govoni;Pathol. Oncol. Res.,2021

5. Lactate induces cisplatin resistance in s. cerevisiae through a rad4p-dependent process;Amaral;Oxid. Med. Cell Longev.,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of ESM1 in the lipids metabolic reprogramming and angiogenesis of lung adenocarcinoma cells;Heliyon;2024-09

2. The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets;Clinical and Translational Medicine;2024-08